Loading the state's markets…
Loading the state's markets…
Medicare volume, surgeons and outlook for 29 device-driven procedures, CMS 2024
Share of surgeons' claims in surgery centers and offices.
Today's surgeons with a 50%+ chance of no longer billing it here.
Share of the named cases done by the 10 busiest surgeons.
MedaRep names every surgeon in each market, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Decompression & minimally invasive spine | 7 | 255−15%/yr | −15%/yr | 1.60.6× | 0% | 290 in 2030+2%/yr |
| Cervical fusion & disc arthroplasty | 0 | 110−11%/yr | −11%/yr | 0.70.6× | 0% | 160 in 2030+6.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Debridement & negative-pressure wound therapy | 39 | 5,795−9.6%/yr | −9.6%/yr | 34.80.4× | 20% | 6,030 in 2030+0.7%/yr |
| Skin substitutes & wound grafts | 4 | 721−5.3%/yr | −5.3%/yr | 2.60.5× | 14% | 740 in 2030+0.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Radiofrequency ablation (facet, genicular, basivertebral) | 16 | 850−3.9%/yr | −3.9%/yr | 5.10.7× | 26% | 730 in 2030−2.5%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Dialysis access | 4 | 340−15%/yr | −15%/yr | 2.20.4× | 5% | 390 in 2030+2.3%/yr |
| Peripheral arterial intervention | 1 | 250−14%/yr | −14%/yr | 1.50.3× | 0% | 260 in 2030+0.5%/yr |
| Superficial venous ablation | 3 | 188−9.3%/yr | −9.3%/yr | 1.10.3× | 100% | 430 in 2030+15%/yr |
| Carotid revascularization | 0 | 161−5.5%/yr | −5.5%/yr | 1.01.0× | 0% | 670 in 2030+27%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Hernia repair | 2 | 755−6.9%/yr | −6.9%/yr | 5.10.9× | 0% | 940 in 2030+3.8%/yr |
| Cholecystectomy & appendectomy | 3 | 578−9.6%/yr | −9.6%/yr | 3.81.1× | 0% | 630 in 2030+1.4%/yr |
| Colorectal resection | 1 | 264−7.9%/yr | −7.9%/yr | 1.71.1× | 0% | 170 in 2030−7.1%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Kidney stone management | 11 | 5,521+56%/yr | +56%/yr | 35.47.6× | 0% | 540 in 2030−32%/yr |
| BPH procedures | 6 | 406−1.3%/yr | −1.3%/yr | 2.60.6× | 0% | 340 in 2030−2.8%/yr |
| Hysterectomy, hysteroscopy & ablation | 3 | 290−6%/yr | −6%/yr | 2.00.6× | 7% | 370 in 2030+4%/yr |
| Incontinence, prolapse & sacral neuromodulation | 2 | 101−14%/yr | −14%/yr | 0.60.3× | 0% | 40 in 2030−13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 4 | 254−3.5%/yr | −3.5%/yr | 1.60.5× | 0% | 510 in 2030+12%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Breast biopsy & localization | 16 | 918−3.4%/yr | −3.4%/yr | 6.30.7× | 0% | 1,010 in 2030+1.6%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| CGM & insulin pump management | 30 | 2,429+36%/yr | +36%/yr | 15.10.5× | 18% | 4,270 in 2030+9.9%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Pacemaker, ICD & CRT implantation | 16 | 574−6.2%/yr | −6.2%/yr | 3.80.8× | 0% | 530 in 2030−1.4%/yr |
| EP ablation | 10 | 404+10%/yr | +10%/yr | 2.10.6× | 0% | 870 in 2030+14%/yr |
| LAA occlusion & loop recorders | 13 | 319+15%/yr | +15%/yr | 1.70.5× | 0% | 450 in 2030+5.7%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Coronary intervention (PCI) | 17 | 602−13%/yr | −13%/yr | 3.00.6× | 0% | 600 in 20300%/yr |
| Structural heart (TAVR, TEER) | 15 | 221+2.2%/yr | +2.2%/yr | 1.10.6× | 0% | 460 in 2030+13%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Cataract & MIGS | 24 | 5,023−10%/yr | −10%/yr | 31.20.6× | 86% | 4,850 in 2030−0.6%/yr |
| Vitreoretinal surgery | 5 | 254−4%/yr | −4%/yr | 1.60.8× | 100% | 240 in 2030−1.2%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Colonoscopy & upper endoscopy | 77 | 12,348−6.2%/yr | −6.2%/yr | 81.70.6× | 16% | 12,100 in 2030−0.4%/yr |
| ERCP & endoscopic ultrasound | 6 | 387−3.6%/yr | −3.6%/yr | 2.50.7× | 0% | 440 in 2030+2.2%/yr |
| Bronchoscopy & lung nodule | 3 | 224−7.6%/yr | −7.6%/yr | 1.40.5× | 0% | 320 in 2030+6.4%/yr |
How the numbers are made · Every state · Compare two markets
Share of the orthopedic, spine, extremity and wound cases CMS names by surgeon, by where the surgeon billed. Open a metro for its ranking.